Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00377156 · ClinicalTrials.gov registry record · Phase 3
Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
A Phase 3 study of Breast Cancer and Prostate Cancer, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- Phase 3
- Development phase
- 213
- Enrollment target
- 20
- Study locations
NCT00377156 is a Phase 3 study of Breast Cancer and Prostate Cancer that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 213 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (92% lower). The trial reports 20 study locations across 9 states.
The verdict
NCT00377156, a Phase 3 study of Breast Cancer and Prostate Cancer, has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 213 participants
- Enrollment target
- 20
- Study locations
Study Summary
RATIONALE: Stereotactic radiation therapy can send x-rays directly to the tumor and cause less damage to normal tissue. Radiation therapy uses high-energy x-rays to kill tumor cells. It is not yet known whether stereotactic radiation therapy is more effective with or without whole-brain radiation therapy in treating patients with brain metastases. PURPOSE: This randomized phase III trial is studying stereotactic radiation therapy and whole-brain radiation therapy to see how well they work compared with stereotactic radiation therapy alone in treating patients with brain metastases.
Conditions Studied
Interventions
- RADIATION radiation therapy
- RADIATION stereotactic radiosurgery
Study Locations (20)
California
- Memorial Medical Center - Modesto
- Kaiser Permanente - Division of Research - Oakland - Oakland
- St. Joseph Hospital Regional Cancer Center - Orange - Orange
- Rohnert Park Cancer Center - Rohnert Park
- Kaiser Permanente Medical Center - Santa Clara Kiely Campus - Santa Clara
- Kaiser Permanente Medical Center - Santa Rosa - Santa Rosa
Georgia
- Northside Hospital Cancer Center - Atlanta
- Saint Joseph's Hospital of Atlanta - Atlanta
- Northeast Georgia Medical Center - Gainesville
- Nancy N. and J. C. Lewis Cancer and Research Pavilion at St. Joseph's/Candler - Savannah
Arizona
- Arizona Oncology-Deer Valley Center - Phoenix
- Arizona Oncology Services Foundation - Scottsdale
Colorado
- University of Colorado Cancer Center at UC Health Sciences Center - Aurora
- Veterans Affairs Medical Center - Denver - Denver
Florida
- Mayo Clinic - Jacksonville - Jacksonville
- Florida Hospital Cancer Institute at Florida Hospital Orlando - Orlando
Idaho
- Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center - Boise
Illinois
- Northwest Community Hospital - Arlington Heights
Kansas
- Via Christi Cancer Center at Via Christi Regional Medical Center - Wichita
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 213 participants |
| Start Date | 2006-07 |
| Est. Completion | 2019-12-15 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00377156
The ClinicalTrials.gov registry entry for NCT00377156 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 213 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (92% lower). The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which radiation therapy is the first listed.
NCT00377156 reports 20 study locations spanning 9 distinct geographic areas - top geographies include California, Georgia, Arizona.
Frequently Asked Questions
What is clinical trial NCT00377156 about?
NCT00377156 is a clinical study titled "Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases". RATIONALE: Stereotactic radiation therapy can send x-rays directly to the tumor and cause less damage to normal tissue. Radiation therapy uses high-energy x-rays to kill tumor cells. It is not yet known whether stereotactic radiation therapy is more effective with or without whole-brain radiation th...
What is the current status of trial NCT00377156?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 213 participants. The study started on 2006-07. Estimated completion is 2019-12-15.
What conditions does trial NCT00377156 study?
This clinical trial studies the following conditions: Breast Cancer, Prostate Cancer, Lung Cancer, Metastatic Cancer, Cognitive/Functional Effects.
What interventions are being tested in trial NCT00377156?
The interventions under investigation include: radiation therapy (RADIATION), stereotactic radiosurgery (RADIATION).
Who is sponsoring clinical trial NCT00377156?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00377156 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
RECRUITING · Phase 3
-
Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy
RECRUITING · Phase 3
-
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
RECRUITING · Phase 3
-
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
RECRUITING · Phase 3
-
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer
RECRUITING · Phase 3
-
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.